Reactions Weekly

, Volume 1673, Issue 1, pp 8–8 | Cite as

Generic vs brand-name angiotensin II receptor blockers

Clinical study


  1. Leclerc J, et al. Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada. A Population-Based Time Series Analysis. Circulation: Cardiovascular Quality and Outcomes 10: e003891, 3 Oct 2017. Available from: URL:

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations